KZA 0.00% 8.0¢ kazia therapeutics limited

Dude, the trial is evaluating paxalisib asmonotherapy treatment...

  1. 69 Posts.
    lightbulb Created with Sketch. 8
    Dude, the trial is evaluating paxalisib asmonotherapy treatment in patients with relapsed/refractory primary central nervous systemlymphoma (r/r PCNSL). These patients are not ok, aye. They've already been through absolute torture. They are dying.

    They're enrolling because they don't want to die.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.